Molecular mechanism of action
The effects of $\beta_1$-adrenomimetics are mediated through a complex intracellular cascade. The receptor is coupled to a stimulatory Gs protein, which activates the enzyme adenylyl cyclase. This leads to a rapid increase in intracellular cyclic AMP (cAMP) concentration.
Subsequent steps of the cascade:
- The accumulation of cAMP activates protein kinase A.
- The enzyme phosphorylates calcium channels in the cell membrane, causing them to open.
- There is a massive influx of $Ca^{2+}$ ions into the cytoplasm from the extracellular space, as well as calcium mobilization from the sarcoplasmic reticulum.
As a result, cytoplasmic calcium concentration rises sharply, which triggers the physiological cellular response.
Effects on the heart and other organs
Calcium accumulation affects various cardiac structures differently. In the working myocardium, $Ca^{2+}$ ions bind to troponin C. The spatial structure of the troponin-tropomyosin complex changes, removing the block on contractile proteins, and actin freely interacts with myosin. Clinically, this manifests as a marked increase in myocardial contractility.
Effects on the conduction system:
- Sinoatrial node: automaticity increases, leading to an elevated heart rate.
- Atrioventricular node: increased calcium influx facilitates impulse conduction and enhances node automaticity.
- Purkinje fibers: automaticity also increases.
In addition to cardiac effects, $\beta_1$-adrenomimetics act on juxtaglomerular cells of the kidneys. Stimulation of these cells causes enhanced renin secretion, ultimately leading to the formation of angiotensin II and systemic activation of the renin-angiotensin-aldosterone system (RAAS).
Dobutamine: characteristics and clinical use
Dobutamine is a classic representative of this group. Chemically, it is a racemic mixture of two stereoisomers. Both isomers are $\beta_1$-receptor agonists, but the (+)-isomer is 10 times more active. Their effects on vascular $\alpha_1$-adrenergic receptors are of interest: the (-)-isomer acts as a stimulator (agonist), whereas the (+)-isomer acts as a blocker (antagonist). Their effects mutually neutralize each other; therefore, clinically, dobutamine exhibits the properties of a selective $\beta_1$-adrenomimetic.
The drug potently increases myocardial contractility (positive inotropic effect) while having only a moderate effect on heart rate and conduction. In therapeutic dosages, it practically does not alter total peripheral vascular resistance (TPVR).
Pharmacokinetic features:
- Administered exclusively by intravenous infusion.
- The onset of action is in 1–2 minutes, reaching a peak by 10 minutes.
- It is metabolized in the liver by the enzyme COMT (catechol-O-methyltransferase) and excreted by the kidneys.
- With prolonged infusion (more than several days), tolerance develops.
The primary indication is acute heart failure. Adverse effects include tachycardia, arrhythmias, chest pain, and arterial hypertension. The drug increases myocardial oxygen demand, which can enlarge the infarct size in myocardial infarction.
Dopamine as an alternative agent
Dopamine is also used as a cardiotonic agent that stimulates $\beta_1$-adrenergic receptors to increase cardiac output. Its main feature is a dose-dependent effect:
- Low doses: stimulate dopamine $D_1$ receptors. This activates adenylyl cyclase and increases cAMP in vascular smooth muscle cells. The result is vasodilation of renal and visceral vessels, increased renal blood flow, glomerular filtration, diuresis, and sodium excretion. This is a crucial mechanism for preventing renal ischemia in cardiogenic shock.
- Moderate doses: primarily stimulate cardiac $\beta_1$-adrenergic receptors.
- High doses: begin to stimulate $\alpha_1$-adrenergic receptors, causing systemic vasoconstriction and elevated blood pressure.
Dopamine is rapidly degraded by MAO (monoamine oxidase) and COMT enzymes; therefore, it is administered parenterally only. It is not suitable for the treatment of chronic heart failure. Cardiac adverse effects are similar to those of dobutamine (arrhythmias, tachycardia, risk of angina pectoris).
Briefly: answers to topical questions
What are the contraindications to the use of dobutamine?
The use of dobutamine is limited in the following cases:
- Hypertrophic cardiomyopathy — dobutamine stress echocardiography is not recommended due to a high risk of inducing ventricular arrhythmias; a false-positive increase in the left ventricular outflow tract pressure gradient is also possible.
- Dilated cardiomyopathy — regular periodic infusions are not recommended for improving prognosis.
- Pregnancy — dobutamine should not be used; it may be used only for life-saving indications.
- Breastfeeding — risk cannot be ruled out.
In what conditions is the use of dopamine indicated?
Dopamine is indicated for acute cardiovascular failure and shock states of various origins:
- Acute cardiovascular failure.
- Cardiogenic, postoperative, septic, and anaphylactic shock.
- Hypodynamic hypovolemic shock — administered concurrently with circulating blood volume replacement.
- In hemorrhage associated with regional anesthesia and sympathetic blockade, and when it is necessary to gain time for establishing additional intravenous lines.
To memorize the dose-dependent effects of dopamine, use the abbreviation DBA (from low to high doses): D — Dopaminergic (renal vasodilation), B — Beta-1 (cardiac stimulation), A — Alpha-1 (vasoconstriction).
Class and exam questions
Why are dobutamine and dopamine not prescribed in tablets?
Both drugs are rapidly degraded by enzymes in the gastrointestinal tract and liver during first-pass metabolism, which is why they are effective only via intravenous infusion.
How does dobutamine affect alpha-1 adrenergic receptors?
The drug contains two isomers: one stimulates these receptors, while the other blocks them. As a result, their actions mutually neutralize each other, and systemic vasospasm does not occur.
For what purpose are low doses of dopamine used?
In low doses, dopamine stimulates D1 receptors, dilating renal vessels. This increases diuresis and protects the kidneys from ischemic damage during shock states.
What else to study on this topic
- Detailed mechanism of calcium ion interaction with the troponin complex
- Comparative characteristics of the effects of dobutamine and dopamine on myocardial oxygen demand
- The role of MAO and COMT enzymes in catecholamine degradation
- Mechanisms of tolerance development during prolonged infusion of beta-adrenomimetics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Beta-1 adrenomimetics" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs Acting on Adrenergic Synapses"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.